NEW YORK (GenomeWeb News) – For the second month in a row, shares of Myriad Genetics rose sharply, pacing gainers in the GenomeWeb Daily News Index.

The GWDN Index climbed 5 percent in February, outpacing the Down Jones Industrial Average (+ 4 percent) and matching the Nasdaq (+ 5 percent) for the month. However, it trailed the Nasdaq Biotech Index, which gained 8 percent month over month.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: mouse genome functional analysis, more sensitive chromatin immunoprecipitation, and more.

The Center for Data Innovation and HealthITNow argue for re-building of genomic research infrastructure.

A Senate committee has unanimously approved a bill to require articles resulting from federally funded projects to be made publicly available, according to ScienceInsider.

The US is heading toward another budget showdown, Nature News says.